Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SanDisk (SNDK) vs Viatris Inc (VTRS) Price & Performance

Viatris IncTrade

Price performance (Past 24H)

Key statistics

SanDisk vs Viatris Inc — how do they compare? SanDisk trades at $1,588.63 (market cap $232.61B), while Viatris Inc trades at $17.64 (market cap $20.03B). The key difference: SanDisk is far larger — about 11.6× Viatris Inc's market cap, and Viatris Inc pays a 2.75% dividend while SanDisk pays none. Which is the better fit depends on your goals — on Pluang, investors hold SanDisk for 8 Days and Viatris Inc for 57 Days on average.

SNDKVTRS
Market Cap
$232.61B$20.03B
Volume
9,218,05414,109,977
Sector
TechnologyHealth
52-Week High
$2.34K$18.27
52-Week Low
$116.91$9.74
Typical Hold Time
8 Days57 Days
Enterprise Value
$228.03B$32.15B
Dividend Yield
—2.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SanDisk

No Aura AI signal available yet.

Viatris Inc

Viatris (VTRS) trades at $17.625, up 0.77% with a bullish technical signal. The company shows mixed fundamentals with declining revenue from $16.3B in 2022 to $14.3B in 2025 and negative net income margins, though recent quarters have beaten EPS estimates. Positive cash flow trends and a $0.12 dividend signal financial stability. Analyst consensus is mixed with 38% buy ratings and a $22.17 price target suggesting 26% upside.

The outlook balances operational strength against profitability challenges. Investment appeal lies in value metrics (P/S 1.38), consistent earnings beats, and dividend yield, but risks include sustained negative margins, high debt, and competitive pressures. The stock's re-rating depends on margin improvement and pipeline execution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SNDK
81% Buy19% Sell
Avg holding period · 8 Days
VTRS
100% Buy0% Sell
Avg holding period · 57 Days

Top news

Latest headlines on both assets

About SanDisk

Sandisk is a semiconductor memory company specializing in NAND flash technology. Its storage products support consumer devices, enterprise systems, and cloud and AI infrastructure.

Read more on SNDK →

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS →